Over the past 2 decades, the diagnostic classification of dementias has been continuously adapted to the increasing knowledge derived from clinical symptomatology, neuropathology, biochemistry, and clinicopathological

comparisons. Before, dementias were attributed primarily to cerebral vascular insufficiency. Later, with the diagnosis of Alzheimer’s disease (AD) predominating, further differentiations were categorized: frontotemporai dementia (FTD), dementia with Lewy bodies (DLB), vascular dementia (VD), prion disease, dementia with argyrophilic grains, British dementia, and Inhibitors,research,lifescience,medical many more. This development was driven by the results of molecular analyses of the abnormal protein deposits in the brain of the respective diseases in relation to the clinical syndromes. The careful clinical and neurochemical investigation of dementias has led to practical guidelines

Inhibitors,research,lifescience,medical and improvements in current treatment and care, eg, the use of atypical neuroleptics in patients with DLB due to the high susceptibility to side effects by treatment with typical antipsychotics. More excitingly, the dissection Inhibitors,research,lifescience,medical of the molecular mechanisms and species involved in the aggregation process may allow for the development of specific therapies, which may, in the future, contribute to the prevention and treatment of neurodegenerative diseases. The following diseases are characterized by the deposition of protein aggregates, termed amyloid, derived from the Greek

amylum (starch, sugar); the term was first introduced by Virchow in 1854 on the basis of color after staining Inhibitors,research,lifescience,medical with iodine, since he assumed that polysaccharides were the major constituents of amyloid deposits in peripheral tissues.1 The secondary structure of amyloid deposits both in the brain as well as in peripheral organs shows a strong tendency towards formation of β-pleated sheets; the tertiary structure forms high-order quasi-crystalline Tofacitinib research buy complexes Inhibitors,research,lifescience,medical that are biréfringent under polarized light (eg, when stained with Congo red), and fibrils can be identified by electron microscopy.1,2 Table I lists the neurodegenerative diseases associated with deposition of abnormal proteins in the brain. Table I. Neurodegenerative diseases are associated with deposition of abnormal proteins in brain. BSE, bovine spongiform encephalopathy. Alzheimer’s disease AD is the most common form of dementia. It affects about 20 to 30 million people worldwide.3,4 The prevalence increases exponentially with age between 55 to 64 years (less than 1 %) ending up at over 20% in the over85 age-group.5 Clinically, AD is characterized by find more progressive cognitive deficits such as impairment of memory and orientation.